PhenoTips Closes CAD $2.5M Funding Round Led by GreenSky Capital for Software to Transform Medical Genetics
22 Sep, 2021
-Surface Ophthalmics, a Pleasanton CA-based pharmaceutical company, raised $25M in funding.
– The round was led by both new and existing investors made up of institutional, healthcare-focused, and other accredited investors, including members of the Surface Board of Directors.
– The company intends to use the funds to advance its clinical programs in ocular diseases.